IONIQ hosts Salt Lake City Mayor Mendenhall at its Office
Salt Lake City, UT, May 2, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) was honored to welcome Salt Lake City Mayor Mendenhall to its office today. During the Mayor’s visit, Michael Garff, IONIQ COO, shared how the Company is developing a Multi-Cancer Screen to help physicians confidently accelerate their diagnoses to the earliest, most-treatable stages when money and lives can be saved. We invite you to watch the video interview by following this link.
About IONIQ Sciences, Inc.
IONIQ Sciences, Inc. is developing an advanced multi-cancer screening technology for early detection that has the potential to expand the therapeutic window, dramatically improve survivability and reduce the cost of healthcare. IONIQ Sciences operates at the confluence of its Electrical Impedance Analytics (EIA) or bioimpedance technology and Artificial Intelligence (AI). IONIQ Science’s first product utilizing its proprietary analytic platform, the IONIQ ProLung Test™ for lung cancer, has been designated a Breakthrough Device by the U.S. FDA. For more information visit: www.IONIQsciences.com
IONIQ Sciences is proud to be a key supporter and member of the newly formed BioHive, a collective representing the life science and healthcare innovation ecosystem. By embracing diversity and collaboration, BioHive has become the fastest-growing life science community in America and their innovations are improving the lives of millions of patients. To learn more, visit: www.biohive.com
IONIQ Sciences, Inc.
350 W. 800 N., Suite 214
Salt Lake City, Utah 84103